Achieve Life Sciences Announces Participation at Fall Investor Conferences
September 07, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update
August 11, 2022 16:05 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022
July 28, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, July 28, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Global Smoking Cessation and Nicotine De-Addiction Products Market to 2028 - Industry Analysis, Trends, Market Size and Forecasts
July 19, 2022 06:23 ET
|
Research and Markets
Dublin, July 19, 2022 (GLOBE NEWSWIRE) -- The "Smoking Cessation and Nicotine De-Addiction Products Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been...
Smoking Cessation and Nicotine De-Addiction Market to Reach US$ 27.84 Bn by 2031: TMR Study
July 18, 2022 12:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, July 18, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Analysis of smoking cessation industry statistics over the past few decades has found that...
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
July 01, 2022 16:05 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation
June 29, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference
June 21, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users
June 01, 2022 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space
May 26, 2022 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Nicotine Surges as Smoking Sags.” To hear...